Literature DB >> 32709954

The highs and lows of Medisoft as an audit tool: lessons from a 5-year upper eyelid ptosis audit.

Samantha Vicki Hunt1, Richard Caesar2.   

Abstract

BACKGROUND: Increasing demand for surgeon accountability requires regular audit of individual and institutional performances. Electronic record systems proclaim efficient audit systems, but how does Medisoft live up to the hype? We present our experiences and examine how well Medisoft's audit suite meets clinical audit needs.
METHODS: Medisoft audit suite was used to audit all ptosis procedures undertaken during 2010-14 in Gloucestershire Hospitals NHS Foundation Trust. Repeat audit identified all ptosis procedures done in the trust since Medisoft was introduced; these data were cross-referenced to determine true re-operation rates.
RESULTS: 350 operations were performed on 304 patients over 427 eyes in 5 years. 40 of 304 patients (13%) have thus far required more than one operation on at least one eye. Cross-referencing the data revealed that 11 of these patients' audit-period operations were re-operations, and 18 patients were re-operated after the audit period. In total 26/40 patients (65%) would have been missed if the data had not been cross-referenced. 17 patients had post-operative complications recorded, 7 of whom had repeat surgery.
CONCLUSIONS: Medisoft supports high volume audits, reducing overall workload and increasing efficiency. However, consistent use across clinical staff is necessary to ensure all data are recorded and available for audit. When assessing re-operation rates, search parameters must be widened and cross-referenced to prevent missing vital information regarding procedures performed outside of the audit window. This could be eliminated in future if Medisoft made small changes to input of data that highlights repeat operations and their indications.

Entities:  

Mesh:

Year:  2020        PMID: 32709954      PMCID: PMC8027823          DOI: 10.1038/s41433-020-1113-8

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

Review 1.  A systematic review of comparison of upper eyelid involutional ptosis repair techniques: efficacy and complication rates.

Authors:  Suzie Chang; Craig Lehrman; Kamel Itani; Rod J Rohrich
Journal:  Plast Reconstr Surg       Date:  2012-01       Impact factor: 4.730

2.  Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK.

Authors:  Miranda Buckle; Paul H J Donachie; Robert L Johnston
Journal:  Br J Ophthalmol       Date:  2015-06-29       Impact factor: 4.638

3.  British Oculoplastic Surgery Society (BOPSS) National Ptosis Survey.

Authors:  E Scoppettuolo; V Chadha; C Bunce; J M Olver; M Wright
Journal:  Br J Ophthalmol       Date:  2008-06-20       Impact factor: 4.638

4.  Outcome and influencing factors of external levator palpebrae superioris aponeurosis advancement for blepharoptosis.

Authors:  Timothy J McCulley; Robert C Kersten; Dwight R Kulwin; William J Feuer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2003-09       Impact factor: 1.746

5.  The Cataract National Dataset electronic multicentre audit of 55,567 operations: when should IOLMaster biometric measurements be rechecked?

Authors:  N E Knox Cartwright; R L Johnston; P D Jaycock; D M Tole; J M Sparrow
Journal:  Eye (Lond)       Date:  2009-08-14       Impact factor: 3.775

6.  The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications.

Authors:  A C Day; P H J Donachie; J M Sparrow; R L Johnston
Journal:  Eye (Lond)       Date:  2015-02-13       Impact factor: 3.775

7.  Distribution and extent of electronic medical record utilisation in eye units across the United Kingdom: a cross-sectional study of the current landscape.

Authors:  Shin Bin Lim; Humma Shahid
Journal:  BMJ Open       Date:  2017-05-17       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.